IMMUNIC, INC.
Data quality: 83%
IMUX
Nasdaq
Manufacturing
Chemicals
$1.29
▲
$0.10
(8.40%)
Mkt Cap: 168.30 M
Price
$1.29
Mkt Cap
168.30 M
Day Range
$1.18 — $1.29
52-Week Range
$0.51 — $1.51
Volume
1,195,171
Open $1.18
50D / 200D Avg
$0.98
31.58% above
50D / 200D Avg
$0.84
54.36% above
Quick Summary
Key Takeaways
Negative free cash flow of -85.97 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-437.61%
Below sector avg (-51.02%)
ROIC-364.54%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio1.31
Interest CoverageN/A
Valuation
PE (TTM)
-1.73
Above sector avg (-1.98)
P/B Ratio16.03
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.7 | -2.0 |
| P/B | 16.0 | 5.1 |
| ROE % | -437.6 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -97.17 M |
| ROE | -437.61% | ROA | -190.29% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -85.97 M |
| ROIC | -364.54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.31 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 9.19 M | Tangible Book Value | 10.50 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.73 | Forward P/E | N/A |
| P/B Ratio | 16.03 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -51.08% | ||
| Market Cap | 168.30 M | Enterprise Value | 133.17 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.62 | Revenue / Share | N/A |
| FCF / Share | -0.66 | OCF / Share | -0.66 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 88.47% |
| SBC-Adj. FCF | -95.43 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -97.17 M | -100.51 M | -93.61 M | -120.41 M | -92.95 M |
| EPS (Diluted) | -0.62 | -1.00 | -2.11 | -3.78 | -3.93 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -103.23 M | -98.05 M | -99.22 M | -119.49 M | -91.67 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 81.98 M | 80.05 M | 83.22 M | 71.26 M | 61.12 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 168,000.0 | 134,000.0 | 111,000.0 | 77,000.0 | 85,000.0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 24.05 M | 40.87 M | 54.30 M | 127.75 M | 139.10 M |
| Total Liabilities | 30.73 M | 22.44 M | 25.37 M | 14.07 M | 11.99 M |
| Shareholders' Equity | -6.67 M | 18.43 M | 28.93 M | 113.68 M | 127.12 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 15.48 M | 35.67 M | 46.67 M | 106.75 M | 86.86 M |
| Current Assets | 22.87 M | 39.33 M | 52.53 M | 125.86 M | 104.99 M |
| Current Liabilities | 30.62 M | 22.18 M | 24.73 M | 13.08 M | 11.40 M |
{"event":"ticker_viewed","properties":{"ticker":"IMUX","listing_kind":"stock","pathname":"/stocks/imux","exchange":"Nasdaq","country":"US"}}